| 摘要 |
The present application describes disubstituted pyrazolines and triazolines of formulae I and II:or pharmaceutically acceptable salt forms thereof, wherein one of M<1 >and M<2 >maybe N and D may be a variety of N-containing groups, which are useful as inhibitors of factor Xa.
|
